Arcus is an oncology-focused biopharmaceutical company leveraging its deep cross-discipline expertise to discover highly differentiated therapies and develop a broad portfolio of novel combinations addressing significant unmet needs.
Arcus’s lead small molecule programs target the adenosine axis, which has been shown to play a significant role in driving immuno-suppression in the tumor micro-environment.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.